Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]
作者
Tiina Mustonen,Ilkka Rauma,Päivi Hartikainen,Johanna Krüger,Marja Niiranen,Tuomas Selander,Sakari Simula,Anne M. Remes,Hanna Kuusisto